Related Experiment Video

Updated: Jul 9, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity

Hyo Jin Kang1, Hee Jeong Kim, Sang Hoon Kwon

  • 1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, Washington DC, 20057-1469, USA.

Cancer Chemotherapy and Pharmacology
|December 13, 2007
PubMed
Abstract

Insights

BRCA1 protein levels influence breast cancer cell response to the prodrug 5F-203. Normal BRCA1 amounts may predict better patient response to this chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • BRCA1 is a tumor suppressor gene involved in DNA repair.
  • 5F-203 is a novel chemotherapeutic prodrug activated by the enzyme CYP1A1.
  • CYP1A1 is induced by 5F-203 and also metabolizes it.

Purpose of the Study:

  • To investigate the impact of BRCA1 expression levels on 5F-203 efficacy in breast cancer.
  • To determine how BRCA1 affects 5F-203-induced gene expression and cytotoxicity.
  • To explore the relationship between BRCA1, CYP1A1, and drug response.

Main Methods:

  • Utilized molecular biology techniques including gene knockdown and overexpression.
  • Employed reporter assays (XRE-Luc), RT-PCR, and Western blotting to assess gene expression.
  • Measured CYP1A1 activity (EROD) and cell viability (MTT assays).

Main Results:

  • BRCA1 protein levels modulate 5F-203's induction of CYP1A1 mRNA and enzymatic activity.
  • BRCA1 knockdown decreased 5F-203-induced expression of p53 and p21.
  • Altered BRCA1 levels affected transcription factors (AhR, ARNT) controlling CYP1A1 expression.

Conclusions:

  • BRCA1 plays a significant role in mediating 5F-203 cytotoxicity in breast cancer cells.
  • BRCA1 status influences the effectiveness of the prodrug 5F-203.
  • Patients with normal BRCA1 levels may benefit most from 5F-203 treatment, suggesting potential clinical utility.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...